These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29209327)

  • 21. DNA sensing of dendritic cells in cancer immunotherapy.
    Qian W; Ye J; Xia S
    Front Mol Biosci; 2024; 11():1391046. PubMed ID: 38841190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
    Rozera C; Cappellini GA; D'Agostino G; Santodonato L; Castiello L; Urbani F; Macchia I; Aricò E; Casorelli I; Sestili P; Montefiore E; Monque D; Carlei D; Napolitano M; Rizza P; Moschella F; Buccione C; Belli R; Proietti E; Pavan A; Marchetti P; Belardelli F; Capone I
    J Transl Med; 2015 May; 13():139. PubMed ID: 25933939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
    Hájek R; Butch AW
    Med Oncol; 2000 Feb; 17(1):2-15. PubMed ID: 10713654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell transfer for cancer immunotherapy.
    Zhao L; Zhang S; Kepp O; Kroemer G; Liu P
    Int Rev Cell Mol Biol; 2022; 370():33-64. PubMed ID: 35798506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Report:
    Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
    Front Immunol; 2021; 12():752563. PubMed ID: 35003064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1.
    Yuan X; Duan Y; Xiao Y; Sun K; Qi Y; Zhang Y; Ahmed Z; Moiani D; Yao J; Li H; Zhang L; Yuzhalin AE; Li P; Zhang C; Badu-Nkansah A; Saito Y; Liu X; Kuo WL; Ying H; Sun SC; Chang JC; Tainer JA; Yu D
    Cancer Discov; 2022 Jul; 12(7):1742-1759. PubMed ID: 35420681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of innate immunity in the tumor microenvironment.
    Gonzalez-Gugel E; Saxena M; Bhardwaj N
    Cancer Immunol Immunother; 2016 Oct; 65(10):1261-8. PubMed ID: 27344341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.
    Wang Z; Xu F; Hu J; Zhang H; Cui L; Lu W; He W; Wang X; Li M; Zhang H; Xiong W; Xie C; Liu Y; Zhou P; Liu J; Huang P; Qin XF; Xia X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function.
    Ott PA; Bhardwaj N
    Front Immunol; 2013 Oct; 4():346. PubMed ID: 24194739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.
    Vandenberk L; Belmans J; Van Woensel M; Riva M; Van Gool SW
    Front Immunol; 2015; 6():663. PubMed ID: 26834740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions.
    Falcón-Beas C; Tittarelli A; Mora-Bau G; Tempio F; Pérez C; Hevia D; Behrens C; Flores I; Falcón-Beas F; Garrido P; Ascui G; Pereda C; González FE; Salazar-Onfray F; López MN
    Immunobiology; 2019 Sep; 224(5):697-705. PubMed ID: 31221438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints.
    Hargadon KM
    Clin Transl Med; 2020 Jan; 10(1):374-411. PubMed ID: 32508018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to overcome DC dysregulation in the tumor microenvironment.
    Mestrallet G; Sone K; Bhardwaj N
    Front Immunol; 2022; 13():980709. PubMed ID: 36275666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
    Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
    Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.